Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team..

N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.

2.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group..

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Epub 2010 Jul 19. Erratum in: Science. 2011 Jul 29;333(6042):524.

3.

Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):586-9.

4.

Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.

Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W, Nakabiito C, Msweli L, Kisenge R, Guay L, Mwatha A, Lynn DJ, Eshleman SH, Richardson P, George K, Andrew P, Mofenson LM, Zwerski S, Maldonado Y; HPTN 046 protocol team..

Lancet. 2012 Jan 21;379(9812):221-8. doi: 10.1016/S0140-6736(11)61653-X. Epub 2011 Dec 22.

5.

HIV infection, aging, and immune function: implications for cancer risk and prevention.

Dubrow R, Silverberg MJ, Park LS, Crothers K, Justice AC.

Curr Opin Oncol. 2012 Sep;24(5):506-16. Review.

6.

The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.

Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ.

Clin Infect Dis. 2011 Mar 15;52(6):793-800. doi: 10.1093/cid/ciq243. Review.

7.

Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.

Ray A, Ray S, George AT, Swaminathan N.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD008739. doi: 10.1002/14651858.CD008739.pub2. Review.

PMID:
21833970
8.

Investigating a sexual network of black men who have sex with men: implications for transmission and prevention of HIV infection in the United States.

Hurt CB, Beagle S, Leone PA, Sugarbaker A, Pike E, Kuruc J, Foust EM, Eron JJ Jr, Cohen MS, Hightow-Weidman LB.

J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):515-21. doi: 10.1097/QAI.0b013e31827076a4. Erratum in: J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):e87.

10.

Testing for acute HIV infection: implications for treatment as prevention.

Owen SM.

Curr Opin HIV AIDS. 2012 Mar;7(2):125-30. doi: 10.1097/COH.0b013e3283506613. Review.

PMID:
22314506
11.

Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.

Stuardo V, Agustí C, Godinez JM, Montoliu A, Torné A, Tarrats A, Alcalde C, Martín D, Fernández-Montoli E, Vanrell C, Solé J, Canet Y, Marqueta JM, Mohamed J, Cuenca I, Lonca M, Sirera G, Ferrer E, Domingo P, Lloveras B, Miro JM, De Sanjosé S, Casabona J.

PLoS One. 2012;7(10):e47755. doi: 10.1371/journal.pone.0047755. Epub 2012 Oct 30.

13.

Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.

Tudor Car L, van-Velthoven MH, Brusamento S, Elmoniry H, Car J, Majeed A, Atun R.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD008741. doi: 10.1002/14651858.CD008741.pub2. Review.

PMID:
21678382
14.

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P.

Lancet. 2008 Dec 6;372(9654):1977-87. doi: 10.1016/S0140-6736(08)61842-5.

PMID:
19059048
15.

Abstinence-only programs for HIV infection prevention in high-income countries.

Underhill K, Operario D, Montgomery P.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005421. Review.

PMID:
17943855
16.

Non-neutralizing antibodies in prevention of HIV infection.

Robinson HL.

Expert Opin Biol Ther. 2013 Feb;13(2):197-207. doi: 10.1517/14712598.2012.743527. Epub 2012 Nov 6. Review.

PMID:
23130709
17.

Effectiveness of needle-exchange programmes for prevention of HIV infection.

Hurley SF, Jolley DJ, Kaldor JM.

Lancet. 1997 Jun 21;349(9068):1797-800.

PMID:
9269214
18.
19.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
20.

Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):65-8.

Supplemental Content

Support Center